Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $267.91 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $105.84 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $71.65 | 1 | $0 (2017) |
| Edwards Lifesciences Corporation | $48.12 | 1 | $0 (2018) |
| Bard Peripheral Vascular, Inc. | $30.30 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $12.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $30.30 | 1 | Bard Peripheral Vascular, Inc. ($30.30) |
| 2019 | $117.84 | 2 | Janssen Pharmaceuticals, Inc ($105.84) |
| 2018 | $48.12 | 1 | Edwards Lifesciences Corporation ($48.12) |
| 2017 | $71.65 | 1 | SANOFI-AVENTIS U.S. LLC ($71.65) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2022 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 08/29/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: VACCINE | ||||||
| 04/18/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $105.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/02/2018 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $48.12 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/07/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $71.65 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 312 | 484 | $83,632 | $38,397 |
| 2022 | 6 | 362 | 555 | $94,046 | $44,802 |
| 2021 | 8 | 403 | 621 | $94,060 | $47,795 |
| 2020 | 9 | 381 | 547 | $79,800 | $35,804 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 312 | $60,528 | $27,765 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 108 | $14,364 | $6,855 | 47.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $3,720 | $1,726 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,480 | $1,115 | 32.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,540 | $936.32 | 60.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 349 | $67,706 | $31,418 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 138 | $18,354 | $9,591 | 52.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 19 | $2,676 | $1,296 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,480 | $1,266 | 36.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,276 | $863.00 | 67.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $554.00 | $367.60 | 66.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 174 | 350 | $67,900 | $33,518 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 120 | $15,960 | $8,199 | 51.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 24 | 24 | $4,152 | $2,884 | 69.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 32 | 32 | $2,555 | $2,019 | 79.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 35 | 35 | $1,610 | $656.85 | 40.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 24 | 24 | $1,176 | $443.85 | 37.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 16 | $96.00 | $55.68 | 58.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 11 | 20 | $611.00 | $18.95 | 3.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 289 | $56,066 | $23,372 | 41.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 56 | $7,448 | $3,025 | 40.6% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 51 | 51 | $3,777 | $3,012 | 79.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 18 | 18 | $3,114 | $2,140 | 68.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 24 | $2,928 | $1,548 | 52.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 58 | 59 | $2,714 | $1,098 | 40.4% |
About Dr. Michael Deanda, MD
Dr. Michael Deanda, MD is a Family Medicine healthcare provider based in La Verne, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750381711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Deanda, MD has received a total of $267.91 in payments from pharmaceutical and medical device companies, with $30.30 received in 2022. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($267.91).
As a Medicare-enrolled provider, Deanda has provided services to 1,458 Medicare beneficiaries, totaling 2,207 services with total Medicare billing of $166,799. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location La Verne, CA
- Active Since 07/29/2005
- Last Updated 07/14/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750381711
Products in Payments
- INVOKANA (Drug) $105.84
- SOLIQUA (Drug) $71.65
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $48.12
- Venclose Maven Catheter (Device) $30.30
- PNEUMOVAX 23 (Biological) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in La Verne
Dr. Asif Siddiq, M.d, M.D
Family Medicine — Payments: $1,943
Mr. Habib Bashoura, Md, MD
Family Medicine — Payments: $1,242
Dr. Tiffany Endo, D.o, D.O
Family Medicine — Payments: $115.37
Dr. Lineth Florian, Md, MD
Family Medicine — Payments: $103.12
Dr. Craig Endo, M.d, M.D
Family Medicine — Payments: $84.65
Danny Lock, Md, MD
Family Medicine — Payments: $79.01